Related Experiment Videos
A prisoner with chronic myeloid leukemia
R Navari1, J Horner Catt, M Siegler
1The MacLean Center for Clinical Medical Ethics, Department of Medicine, University of Chicago School of Medicine, Chicago, Illinois 60637-1470, USA.
Bone Marrow Transplantation
|November 11, 1999
Summary
Prisoners with leukemia should receive bone marrow transplants, just like non-inmates. Healthcare access and cost considerations for inmate transplantation must be equitable, ensuring patients receive necessary medical care regardless of incarceration status.
Area of Science:
- Medical Ethics
- Hematology
- Transplantation Medicine
Background:
- Limited discussion exists regarding healthcare access for incarcerated individuals, particularly in specialized fields like tissue and organ transplantation.
- The case highlights a gap in understanding and documenting the provision of advanced medical treatments for prisoners.
Observation:
- A prisoner diagnosed with chronic myelogenous leukemia was identified as a candidate for allogeneic bone marrow transplantation.
- The patient had two HLA-identical siblings available as willing bone marrow donors.
Findings:
- The case suggests that incarcerated individuals should have access to the same standard of healthcare as the general population.
- Ethical, constitutional, and humanitarian principles support equitable treatment in transplantation for prisoners.
Implications:
- This case underscores the need for policies ensuring prisoners receive comprehensive medical care, including complex procedures like bone marrow transplants.
- Healthcare costs should not be a barrier to essential medical treatment for incarcerated patients, mirroring societal standards.
Keywords:
Health Care and Public Health